KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Cash from Financing Activities (2016 - 2025)

CareDx's Cash from Financing Activities history spans 13 years, with the latest figure at -$12.5 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 1280.07% year-over-year to -$12.5 million; the TTM value through Dec 2025 reached -$93.4 million, down 1565.97%, while the annual FY2025 figure was -$93.4 million, 1565.97% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$12.5 million at CareDx, up from -$26.5 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $189.2 million in Q1 2021 and bottomed at -$53.8 million in Q2 2025.
  • The 5-year median for Cash from Financing Activities is -$1.2 million (2023), against an average of $2.6 million.
  • The largest annual shift saw Cash from Financing Activities skyrocketed 25845.31% in 2021 before it crashed 1962.03% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$834000.0 in 2021, then plummeted by 184.41% to -$2.4 million in 2022, then plummeted by 1033.09% to -$26.9 million in 2023, then soared by 96.64% to -$903000.0 in 2024, then plummeted by 1280.07% to -$12.5 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Cash from Financing Activities are -$12.5 million (Q4 2025), -$26.5 million (Q3 2025), and -$53.8 million (Q2 2025).